GATC Biotech

GATC Biotech was a German company specialist in DNA and RNA sequencing for academic and industrial partners worldwide. The company offered sequencing and bioinformatics solutions from single samples up to large-scale projects. 'The Genome and Diagnostic Centre' focusing on Next and Third Generation sequencing was based in the headquarters in Constance, Germany. The fully automated NGS laboratories were certified under ISO 17025. The Sanger sequencing business was located in 'The European Custom Sequencing Centre' in Cologne, Germany. The proximity to Cologne Bonn Cargo GmbH served as the logistical hub within Europe. GATC Biotech was acquired by Eurofins Genomics (part of Eurofins Scientific) in July 2017.

GATC Biotech AG
TypeLimited Company
IndustryBiotechnology
Founded1990 (1990)
HeadquartersKonstanz, Germany
Websitewww.eurofinsgenomics.eu

History

Founded in 1990 the company concentrated in the early days on commercialising a nonradioactive sequencing technology platform,[1] patented by Prof. Pohl one of the founder of GATC.

The direct blotting electrophoresis system, the GATC 1500 was utilised in the European Saccharomyces cerevisiae[2] genome project. In 1996 started the transformation from an instrument manufacturer to a service provider in the field of DNA and RNA sequencing. As part of the Gene Alliance, founded in 1998, the company was involved in the large-scale genome analysis project Aspergillus niger funded by DSM (The Netherlands) and finished in 2001.[3]

In 2006 the company started to develop the next generation sequencing business division adding the Europe's first commercial PacBio RS platform in 2011.

In July 2017 GATC Biotech was acquired by Eurofins Genomics (part of Eurofins Scientific).

Structure of the company

GATC Biotech was a limited company and had several subsidiaries in Europe.

  • GATC Biotech AB, Stockholm, Sweden (100%)
  • GATC Biotech Ltd., Cambridge, United Kingdom (100%)
  • GATC Biotech SARL, Marseille, France (100%)

Products

The range of products covers the Sanger sequencing applications[4] as well as next generation sequencing, such as de novo sequencing, human exome sequencing for clinical settings and RNA-Seq.[5]

References
  1. Beck, S; Pohl, FM (1984). "DNA sequencing with direct blotting electrophoresis". EMBO J. 3 (12): 2905–9. doi:10.1002/j.1460-2075.1984.tb02230.x. PMC 557787. PMID 6396083.
  2. Feldmann, H (1994). "Complete DNA sequence of yeast chromosome II". EMBO J. (Submitted manuscript). 13 (24): 5795–809. doi:10.1002/j.1460-2075.1994.tb06923.x. PMC 395553. PMID 7813418.
  3. M. M. Ramirez-Corredores (Editor), Abhijeet P. Borole (Editor), 2007, Biocatalysis in Oil Refining, Volume 164 (Studies in Surface Science and Catalysis), ISBN 978-0444522122
  4. Elbrecht, Vasco; Feld, Christian K.; Gies, Maria; Hering, Daniel; Sondermann, Martin; Tollrian, Ralph; Leese, Florian (2014). "Genetic diversity and dispersal potential of the stonefly Dinocras cephalotes in a central European low mountain range". Freshwater Science. 33: 181–192. doi:10.1086/674536.
  5. Diversity of research projects
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.